JP2023535792A5 - - Google Patents
Info
- Publication number
- JP2023535792A5 JP2023535792A5 JP2023505756A JP2023505756A JP2023535792A5 JP 2023535792 A5 JP2023535792 A5 JP 2023535792A5 JP 2023505756 A JP2023505756 A JP 2023505756A JP 2023505756 A JP2023505756 A JP 2023505756A JP 2023535792 A5 JP2023535792 A5 JP 2023535792A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- optionally
- amino acid
- acid sequence
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063058978P | 2020-07-30 | 2020-07-30 | |
| US63/058,978 | 2020-07-30 | ||
| PCT/EP2021/071491 WO2022023566A2 (en) | 2020-07-30 | 2021-07-30 | Cd-3 antibodies for the treatment of coronavirus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023535792A JP2023535792A (ja) | 2023-08-21 |
| JP2023535792A5 true JP2023535792A5 (https=) | 2024-08-05 |
Family
ID=77543470
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023505756A Pending JP2023535792A (ja) | 2020-07-30 | 2021-07-30 | コロナウイルス治療のための抗ｃｄ３抗体 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230227555A1 (https=) |
| EP (1) | EP4188440A2 (https=) |
| JP (1) | JP2023535792A (https=) |
| CN (1) | CN116406274B (https=) |
| AU (1) | AU2021316723A1 (https=) |
| CA (1) | CA3185105A1 (https=) |
| IL (1) | IL299744A (https=) |
| WO (1) | WO2022023566A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220332822A1 (en) * | 2021-04-16 | 2022-10-20 | Tiziana Life Sciences Plc | Subcutaneous administration of antibodies for the treatment of disease |
| WO2023218100A1 (en) * | 2022-05-13 | 2023-11-16 | Tiziana Life Sciences Plc | Nasal formulations of foralumab |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4654210A (en) | 1979-04-26 | 1987-03-31 | Ortho Pharmaceutical Corporation | Methods and compositions using complement fixing monoclonal antibody to human T cells |
| US4361549A (en) | 1979-04-26 | 1982-11-30 | Ortho Pharmaceutical Corporation | Complement-fixing monoclonal antibody to human T cells, and methods of preparing same |
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4978745A (en) | 1987-11-23 | 1990-12-18 | Centocor, Inc. | Immunoreactive heterochain antibodies |
| US4975369A (en) | 1988-04-21 | 1990-12-04 | Eli Lilly And Company | Recombinant and chimeric KS1/4 antibodies directed against a human adenocarcinoma antigen |
| WO1991006319A1 (en) | 1989-10-27 | 1991-05-16 | Arch Development Corporation | Methods and compositions for promoting immunopotentiation |
| US6406696B1 (en) | 1989-10-27 | 2002-06-18 | Tolerance Therapeutics, Inc. | Methods of stimulating the immune system with anti-CD3 antibodies |
| US5858784A (en) | 1991-12-17 | 1999-01-12 | The Regents Of The University Of California | Expression of cloned genes in the lung by aerosol- and liposome-based delivery |
| US6491916B1 (en) | 1994-06-01 | 2002-12-10 | Tolerance Therapeutics, Inc. | Methods and materials for modulation of the immunosuppresive activity and toxicity of monoclonal antibodies |
| US7883703B2 (en) * | 2003-11-14 | 2011-02-08 | The Brigham And Women's Hospital, Inc. | Methods of modulating immunity |
| DK2439273T3 (da) * | 2005-05-09 | 2019-06-03 | Ono Pharmaceutical Co | Humane monoklonale antistoffer til programmeret død-1(pd-1) og fremgangsmåder til behandling af cancer ved anvendelse af anti-pd-1- antistoffer alene eller i kombination med andre immunterapeutika |
| MX2008014710A (es) * | 2006-05-19 | 2009-02-12 | Amgen Inc | Anticuerpos para coronavirus del sars. |
| AU2014319921A1 (en) * | 2013-09-11 | 2016-03-17 | Compugen Ltd. | Anti-VSTM5 antibodies and the use thereof in therapy and diagnosis |
| CN116617387A (zh) * | 2016-08-29 | 2023-08-22 | 迪赞纳生命科学公开有限公司 | 抗cd3抗体制剂 |
| EP3634478A4 (en) * | 2017-06-06 | 2021-03-24 | The Brigham and Women's Hospital, Inc. | METHOD OF SUPPRESSION OF MICROGLIA ACTIVATION |
| IL296276A (en) * | 2020-03-10 | 2022-11-01 | Tiziana Life Sciences Plc | Compositions of il-6/il-6r antibodies and methods of use thereof |
-
2021
- 2021-07-30 CN CN202180059947.8A patent/CN116406274B/zh active Active
- 2021-07-30 CA CA3185105A patent/CA3185105A1/en active Pending
- 2021-07-30 JP JP2023505756A patent/JP2023535792A/ja active Pending
- 2021-07-30 IL IL299744A patent/IL299744A/en unknown
- 2021-07-30 AU AU2021316723A patent/AU2021316723A1/en active Pending
- 2021-07-30 US US18/002,591 patent/US20230227555A1/en active Pending
- 2021-07-30 EP EP21762622.5A patent/EP4188440A2/en active Pending
- 2021-07-30 WO PCT/EP2021/071491 patent/WO2022023566A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023515271A5 (https=) | ||
| JP2023517611A5 (https=) | ||
| JP2009511480A5 (https=) | ||
| JP2023535792A5 (https=) | ||
| JP2017538779A5 (https=) | ||
| US20230201497A1 (en) | Method for pulsatile delivery of a gaseous drug | |
| JP2023520323A5 (https=) | ||
| CN117603358B (zh) | 一种广谱新型冠状病毒的双特异性抗体 | |
| CN116406274B (zh) | 用于治疗冠状病毒的cd3抗体 | |
| JP2025501239A5 (https=) | ||
| WO2016036273A1 (ru) | Лекарственное средство для профилактики и лечения заболеваний дыхательных путей | |
| CN115867577A (zh) | 用于预测covid-19肺炎中对il-6拮抗剂反应的生物标志物 | |
| JP2023523096A5 (https=) | ||
| EP4655001A1 (en) | Method for prevention or treatment of coronavirus infection | |
| CN118845782A (zh) | Zinc62678696在防治肺炎中的应用 | |
| Hameed et al. | The possible role of immunoglobulin A monoclonal antibodies against COVID-19 infection | |
| JP2023540175A (ja) | オロチン酸カルボキシアミドトリアゾールを使用するｓａｒｓ－ｃｏｖ－２感染を処置する方法及び組成物 | |
| CN115884770A (zh) | 治疗冠状病毒感染的联用药物及治疗方法 | |
| CN116685351A (zh) | Empacta的结果：一项用于评估托珠单抗在患有covid-19肺炎的住院患者中的功效和安全性的随机、双盲、安慰剂对照、多中心研究 | |
| US11318118B1 (en) | Methods and compositions for treating SARS-CoV-2 infection using carboxyamidotriazole orotate | |
| WO2024156832A1 (en) | Method for prevention or treatment of coronavirus infection | |
| JP2019519470A5 (https=) | ||
| HK40109942A (zh) | 用於年龄疾病的TGF-β治疗剂 | |
| EP4655002A1 (en) | Method for prevention or treatment of coronavirus infection | |
| JP2024523391A (ja) | Ｌｏｎｇ ｃｏｖｉｄ及び／又はｓａｒｓ－ｃｏｖ－２感染急性期後後遺症（ｐａｓｃ）の処置の方法に使用するための抗ｂａｆｆ抗体 |